Skip to main content
. 2016 Jun 7;7(27):41285–41293. doi: 10.18632/oncotarget.9778

Table 2. Univariate and multivariate analysis of factors related to DFS in TNBC cancer patients.

DFS
variable Univariate analysis Multivariate analysis
HR (95 % CI) p value HR (95 % CI) p value
age 1.471(0.752-2.876) 0.259
TNM stage 2.111(1.250-3.566) 0.005 2.263(1.085-4.723) 0.03
tumor size 1.712(1.031-2.842) 0.038 1.387(0.784-2.452) 0.261
node status 2.262(1.175-4.356) 0.015 1.154(0.489-2.727) 0.744
Pathological stage 1.338(0.688-2.601) 0.391
Menopausal status 1.740(0.881-3.435) 0.111
BRCA1 0.321(0.113-0.908) 0.032 0.318(0.110-0.918) 0.034
Anthracyclines based chemo 0.677(0.339-1.354) 0.270
Taxane based chemo 1.555(0.731-3.308) 0.252
AR 2.258(1.155-4.414) 0.017 2.423(1.211-4.848) 0.012

Bold values are statistically significant (P < 0.05)

CI confidence interval

AR androgen receptor

BRCA1 breast cancer-associated gene1